Skip to main content
. Author manuscript; available in PMC: 2025 Nov 4.
Published in final edited form as: J Addict Med. 2025 Aug 21;19(5):631–633. doi: 10.1097/ADM.0000000000001573

TABLE 2.

Average Monthly and Cumulative Change in Starting and Ending Medicaid Buprenorphine Treatment Episodes Post-Unwinding, by Unwinding Status

Change in Starting Episodes Change in Ending Episodes
Average (%) (95% CI) Cumulative (n) Average (%) (95% CI) Cumulative (n)
State unwinding status
 Greatest unwinding −3.9 (−7.3, −0.6) −1843 5.5 (0.8, 10.1) 2320
 Moderate unwinding −2.4 (−6.1, 1.2) −2580 2.2 (−2.6, 6.9) 1806
 Least unwinding −2.0 (−5.6, 1.6) −1333 2.2 (−1.8, 6.3) 1224
Overall −2.6 (−5.3, 0.1) −5756 3.0 (−1.1, 7.0) 5350
Medicaid unwinding status
 Greatest unwinding 2.7 (1.6, 3.7) 3515 5.8 (5.0, 6.6) 6172
 Moderate unwinding 0.0 (−1.0, 1.1) 86 2.2 (1.3, 3.1) 3485
 Least unwinding −2.0 (−3.2, −0.8) −3031 0.5 (−0.3, 1.4) 643
Overall 0.1 (−0.7, 1.0) 570 2.7 (1.9, 3.4) 10,300